Peripheral bloodCD56brightNKcells respond to stem cell factor and adhere to its membrane‐bound form after upregulation of c‐kit-Reference-Cited by-同舟云学术

Peripheral bloodCD56brightNKcells respond to stem cell factor and adhere to its membrane‐bound form after upregulation of c‐kit

Published:2013-11-20 Issue:2 Volume:44 Page:511-520
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Pradier Amandine¹,Tabone‐Eglinger Severine²,Huber Vincent¹,Bosshard Carine¹,Rigal Emmanuel¹,Wehrle‐Haller Bernhard²,Roosnek Eddy¹

Affiliation:

1. Division of HematologyDepartment of Internal MedicineGeneva University Hospitals and University of Geneva Switzerland

2. Department of Cell Physiology and MetabolismGeneva Medical SchoolUniversity of Geneva Geneva Switzerland

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/eji.201343868

Reference51 articles.

1. The relationship of CD16 (Leu‐11) and Leu‐19 (NKH‐1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes;Lanier L. L.;J. Immunol.,1986

2. Comparative studies of human FcRIII‐positive and negative natural killer cells;Nagler A.;J. Immunol.,1989

3. The biology of human natural killer-cell subsets

4. Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset

5. What does it take to make a natural killer?

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phosphodiesterase 4A confers resistance to PGE2‐mediated suppression in CD25 + /CD54 + NK cells;EMBO reports;2021-01-22

2. Autoantibody-positive healthy individuals with lower lupus risk display a unique immune endotype;Journal of Allergy and Clinical Immunology;2020-12

3. An Inverse Relationship Between c-Kit/CD117 and mTOR Confers NK Cell Dysregulation Late After Severe Injury;Frontiers in Immunology;2020-06-25

4. Differentiation of c‐Kit + CD24 + natural killer cells into myeloid cells in a GATA‐2‐dependent manner;The FASEB Journal;2020-01-27

5. KIT as a therapeutic target for non-oncological diseases;Pharmacology & Therapeutics;2019-05